source
- Eli Lilly partners with QurCan Therapeutics, pledging up to $237 M per CNS genetic-medicine programEli Lilly announced a collaboration with Canadian biotech QurCan Therapeutics to advance genetic medicines aimed at the central nervous system. Under the deal, Lilly will provide up to $237 millio…
- Sionna Therapeutics cuts 46% of staff after cystic fibrosis trial missSionna Therapeutics announced it will lay off roughly half of its employees as it reassesses its strategy following a recent setback in its cystic fibrosis program. The company’s lead candidate, S…